The scrip opened at Rs 661.0 and touched an intraday high and low of Rs 663.7 and Rs 654.05, respectively, in the session so far. Shares of the company of Lupin Ltd. quoted a 52-week high of Rs 798.9 and a 52-week low of Rs 583.05.
Total market cap of the Lupin Ltd. stood at Rs 30002.83 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 4340.18 crore for the quarter ended 31-Dec-2022, up 4.32 per cent from previous quarter's Rs 4160.46 crore and up 3.46 per cent from the year-ago quarter's Rs 4194.99 crore.
The net profit for latest quarter stood at Rs 153.47 crore, down 71.87 per cent from the corresponding quarter last year.
As of 31-Dec-2022, domestic institutional investors held 16.47 per cent stake in the firm, while foreign institutional investors held 13.98 per cent and the promoters 47.1 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of -92.64 and a price-to-book ratio of 2.79. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Lupin Ltd. belongs to the Pharma - Indian industry.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.